About Biological E. Limited
Data last updated: 05 January 2026
Biological E. Limited is a public limited company based in Andhra Pradesh, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 10 December 1953, the company has been in operation for over 73 years.
Registered with ROC Hyderabad under CIN U01120TG1953PLC001095.
Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.95 Cr. Formerly known as Biological Products Private Limited and Biological Products Limited. It is led by directors including Narsing Rao Singayapally and Peter Baron Piot.
Last AGM: 28 August 2024. Financial statements filed for year ended 31 March 2024. Office: 18/1 And 3 Azamabad Hyderabad, Andhra Pradesh, Telangana, India – 500020.
As per the financials filed for FY 2024, the company reported a revenue of ₹2,708 Cr, a decline of 30% compared to the previous year.
Its group structure includes 4 subsidiaries.
The company is associated with 2 brands - Akorn India, Biological E. As per MCA filings, the company has open charges of ₹2,580.52 Cr and satisfied charges of ₹3,316.04 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biologicale.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address18/1 And 3 Azamabad Hyderabad, Andhra Pradesh, Telangana, India – 500020
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Biological E. Limited
Biological E. Limited has undergone 5 name changes throughout its history. The current legal name is Biological E. Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Biological E. Limited | Current |
| Biological Products Private Limited | Previous |
| Biological Products Limited | Previous |
| Evans Medical Supplies (India) Private Limited | Previous |
| Evans Medical Supplies (India) Limited | Previous |
| Biological Evans Limited | Previous |
CIN History of Biological E. Limited
Biological E. Limited has one previous CIN (Corporate Identification Number): U01120AP1953PLC001095. The current CIN is U01120TG1953PLC001095, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U01120TG1953PLC001095 | Current |
| U01120AP1953PLC001095 | Previous |
Associated Brands with Biological E. Limited
Biological E. Limited operates two associated brands: Akorn India and Biological E. These brands represent Biological E. Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Sterile pharmaceuticals are developed, manufactured, and marketed by Akorn India. | akornindia.com | |
| Vaccines and therapeutics for multiple diseases are developed and marketed. | biologicale.com |
Competitors & Alternatives of Biological E. Limited
Brands and companies operating in the same space as Biological E. Limited include Vaxcyte, Serum Institute of India, RedHill Biopharma and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Vaxcyte
|
Vaccines for infectious diseases are developed using cell-free protein synthesis. | Foster City, United States, United States | 2013 |
Serum Institute of India
|
Vaccines and immuno-biological drugs for infectious diseases are manufactured. | Pune, India, India | 1966 |
RedHill Biopharma
|
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases | Ramat Gan, Israel, Israel | 2009 |
Valneva
|
Prophylactic vaccines for infectious diseases are developed and advanced. | Lyon, France, France | 1999 |
Freeline
|
Gene therapy platform is developed for chronic disease treatments. | Stevenage, United Kingdom, United Kingdom | 2015 |
Vir Biotechnology
|
Developer of therapeutics for the treatment of infectious diseases | San Francisco, United States, United States | 2017 |
Cidara Therapeutics
|
Novel anti-infectives for bacterial and fungal infections are developed. | San Diego, United States, United States | 2013 |
Exela Pharma
|
Sterile injectable pharmaceuticals are manufactured alongside CDMO services. | Lenoir, United States, United States | 2005 |
Gland Pharma
|
Generic injectable drugs are manufactured across therapeutic segments. | Hyderabad, India, India | 1978 |
Luoxin Pharmaceutical Group
|
Developer and manufacturer of pharmaceutical products | Linyi, China, China | 2006 |
Business Activity of Biological E. Limited
Biological E. Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Biological E. Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Biological E. Limited
Biological E. Limited is audited by BRAHMAYYA & CO for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BRAHMAYYA & CO | Locked | Locked | Locked |
Complete auditor history for Biological E. Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Biological E. Limited
Biological E. Limited is currently managed by 9 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Narsing Rao Singayapally
Also directs:
Kaveri Seed Company Ltd., Hbl Engineering Limited, Svln Farm Fields Private Limited and 2 more
|
Additional Director | 07 Oct 2024 | 1 Years 10 Months | Current |
|
Peter Baron Piot
Also directs:
Biocon Biologics Limited
|
Additional Director | 27 Nov 2024 | 1 Years 8 Months | Current |
|
Rudaraju Anand Kumar
Also directs:
Technopharma Pvt Ltd, Biotech Medicals Private Limited, Biotech Pharma Pvt Ltd. and 5 more
|
Whole-Time Director | 16 Oct 2017 | 8 Years 9 Months | Current |
| Ippagunta Yasodhara Rama Krishna Rao | Director | 23 May 2017 | 9 Years 2 Months | Current |
| Mahima Datla | Managing Director | 10 Apr 2013 | 13 Years 4 Months | Current |
| Narender Dev Mantena | Whole-Time Director | 07 Oct 2024 | 1 Years 10 Months | Current |
Financials of Biological E. Limited FY 2024 filings available
Biological E. Limited reported revenue of ₹2,708 Cr (down 30.00% YoY) for FY 2024.
Ten-year financial statements for Biological E. Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Biological E. Limited
Shareholding and ownership data for Biological E. Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Biological E. Limited
Biological E. Limited has 4 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Biological E. Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Be Pharmaceuticals Private Limited | U24100TG2011PTC148362 | Locked |
| Biotech Medicals Private Limited | U24230TG1999PTC032680 | Locked |
| B.E. Investment And Finance Pvt Ltd | U65993TG1987PTC008036 | Locked |
| Vaxenic India Private Limited | U74900TG2015PTC097587 | Locked |
Showing major subsidiaries. Total: 4.
Charges & Borrowings of Biological E. Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Dec 2024 | Citi Bank N.A. | ₹250 Cr | Open |
| 11 Dec 2024 | Citi Bank N.A. | ₹167.8 Cr | Open |
| 01 Dec 2023 | Axis Bank Limited | ₹2.14 Cr | Open |
| 17 Nov 2022 | Others | ₹300 Cr | Open |
| 31 May 2022 | Hdfc Bank Limited | ₹350 Cr | Open |
Total charge records: 84 View all charges
Employees and EPFO Compliance at Biological E. Limited
Biological E. Limited has a workforce of 0 employees as of Sep 20, 2024.
Employee and EPFO history for Biological E. Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Biological E. Limited
GST registrations and filing compliance for Biological E. Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Biological E. Limited
Credit ratings, litigation, and regulatory alerts for Biological E. Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biological E. Limited
MSME payment history for Biological E. Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biological E. Limited
Corporate group structure for Biological E. Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biological E. Limited
MCA filings and documents for Biological E. Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Biological E. Limited
Recent News on Biological E. Limited
Frequently Asked Questions about Biological E. Limited
Biological E. Limited is an active public limited company in the pharma sector based in Andhra Pradesh, Telangana, India. It was incorporated on 10 December 1953 (73+ years old) and is registered under CIN U01120TG1953PLC001095.
Biological E. Limited reported revenue of ₹2,708 Cr for FY 2024 (down 30.00% YoY).
The current directors of Biological E. Limited are:
- Narsing Rao Singayapally - Additional Director
- Peter Baron Piot - Additional Director
- Rudaraju Anand Kumar - Whole-Time Director
- Ippagunta Yasodhara Rama Krishna Rao - Director
- Mahima Datla - Managing Director
- Narender Dev Mantena - Whole-Time Director
- Venkata Subbaraju Penmetsa - Additional Director
- Indira Smriti Rajupusapati - Whole-Time Director
- Mantena Purnima - Whole-Time Director
The primary industry of Biological E. Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Biological E. Limited can be reached at the registered office: 181 And 3 Azamabad Hyderabad, Andhra Pradesh, Telangana, India – 500020, or through the website biologicale.com.
The authorised capital is ₹5 Cr, and the paid-up capital is ₹4.95 Cr.